These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 33840082)

  • 1. Antimicrobial nanomedicine for ocular bacterial and fungal infection.
    Fan W; Han H; Chen Y; Zhang X; Gao Y; Li S; Jin Q; Ji J; Yao K
    Drug Deliv Transl Res; 2021 Aug; 11(4):1352-1375. PubMed ID: 33840082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan Derivatives Active against Multidrug-Resistant Bacteria and Pathogenic Fungi: In Vivo Evaluation as Topical Antimicrobials.
    Hoque J; Adhikary U; Yadav V; Samaddar S; Konai MM; Prakash RG; Paramanandham K; Shome BR; Sanyal K; Haldar J
    Mol Pharm; 2016 Oct; 13(10):3578-3589. PubMed ID: 27589087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic considerations in the treatment of bacterial keratitis.
    Callegan MC; O'Callaghan RJ; Hill JM
    Clin Pharmacokinet; 1994 Aug; 27(2):129-49. PubMed ID: 7955776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis.
    Mannis MJ
    Trans Am Ophthalmol Soc; 2002; 100():243-71. PubMed ID: 12545697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine for the Detection and Treatment of Ocular Bacterial Infections.
    Huang X; Li L; Chen Z; Yu H; You X; Kong N; Tao W; Zhou X; Huang J
    Adv Mater; 2023 Nov; 35(46):e2302431. PubMed ID: 37231939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ forming hydrogel loaded with predatory bacteria treats drug-resistant corneal infection.
    Liu Y; Guo W; Wang W; Zhang H; Jin Y
    J Control Release; 2023 Dec; 364():393-405. PubMed ID: 37898345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of antimicrobial resistance among hospital-associated pathogens.
    Khan A; Miller WR; Arias CA
    Expert Rev Anti Infect Ther; 2018 Apr; 16(4):269-287. PubMed ID: 29617188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic resistance in ocular bacterial pathogens.
    Sharma S
    Indian J Med Microbiol; 2011; 29(3):218-22. PubMed ID: 21860100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy.
    Fu T; Yi J; Lv S; Zhang B
    J Liposome Res; 2017 Sep; 27(3):228-233. PubMed ID: 27601177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial peptides: Possible anti-infective agents.
    Lakshmaiah Narayana J; Chen JY
    Peptides; 2015 Oct; 72():88-94. PubMed ID: 26048089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of nanomedicine targeting scar-forming myofibroblasts to attenuate corneal scarring and haze.
    Ibrahim Al-Mashahedah AM; Kanwar RK; Kanwar JR
    Nanomedicine (Lond); 2019 Apr; 14(8):1049-1072. PubMed ID: 30901304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic implications of nanomedicine for ocular drug delivery.
    Meng T; Kulkarni V; Simmers R; Brar V; Xu Q
    Drug Discov Today; 2019 Aug; 24(8):1524-1538. PubMed ID: 31102733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Importance of Nanomedicine in Prophylactic and Theranostic Intervention of Bacterial Zoonoses and Reverse Zoonoses in the Era of Microbial Resistance.
    Prasad M; Ghosh M; Kumar R; Brar B; Surjith KP; Lambe UP; Ranjan K; Banerjee S; Prasad G; Kumar Khurana S; Kharb P
    J Nanosci Nanotechnol; 2021 Jun; 21(6):3404-3452. PubMed ID: 34739797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Updates on Treatment of Ocular Microbial Infections by Stem Cell Therapy: A Review.
    Teh SW; Mok PL; Abd Rashid M; Bastion MC; Ibrahim N; Higuchi A; Murugan K; Mariappan R; Subbiah SK
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29438279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent insights on nanomedicine for augmented infection control.
    Singh S; Hussain A; Shakeel F; Ahsan MJ; Alshehri S; Webster TJ; Lal UR
    Int J Nanomedicine; 2019; 14():2301-2325. PubMed ID: 31114188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging antibacterial nanomedicine for enhanced antibiotic therapy.
    Wang S; Gao Y; Jin Q; Ji J
    Biomater Sci; 2020 Dec; 8(24):6825-6839. PubMed ID: 32996490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Non-Infectious Corneal Injury: Review of Diagnostic Agents, Therapeutic Medications, and Future Targets.
    Dang DH; Riaz KM; Karamichos D
    Drugs; 2022 Feb; 82(2):145-167. PubMed ID: 35025078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new perspective in ocular infection and the role of antibiotics.
    Miyanaga Y
    Ophthalmologica; 1997; 211 Suppl 1():9-14. PubMed ID: 9065932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of prophylactic antibiotic drops on ocular microbiota and physiology during silicone hydrogel lens wear.
    Ozkan J; Zhu H; Gabriel M; Holden BA; Willcox MD
    Optom Vis Sci; 2012 Mar; 89(3):326-35. PubMed ID: 22246331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and Potential Utility of a Novel Non-Invasive Ocular Delivery Platform.
    Wang WJ; Snider N
    Pharmaceutics; 2023 Sep; 15(9):. PubMed ID: 37765311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.